FDA Panel Votes Against Veru’s COVID-19 Pill

Signage extracurricular of the Food and Drug Administration (FDA) office successful White Oak, Md., connected Aug. 29, 2020. (Andrew Kelly/Reuters) A sheet of extracurricular advisers to the U.S. health regulator connected Wednesday voted against authorizing Veru Inc.’s drug for treating high-risk patients hospitalized with COVID-19, citing aggregate concerns implicit efficacy and information information being based connected a tiny trial. The sheet voted 8&nd...